Rechercher dans ce blog

Monday, November 30, 2020

Cyber Monday set to be biggest online shopping day in US history - Reuters

FILE PHOTO: Amazon workers perform their jobs inside of an Amazon fulfillment center on Cyber Monday in Robbinsville, New Jersey, U.S., December 2, 2019. REUTERS/Lucas Jackson

India Top News

Aishwarya Venugopal

(Reuters) - Cyber Monday was set to become the biggest online shopping day ever for the United States, garnering up to $11.4 billion as the coronavirus pandemic prompts consumers to stay at home and turn to the internet for their holiday shopping needs.

The robust performance comes despite nearly two months of offers since Amazon.com Inc held its Prime Day sales event in October, with retailers seeking to recoup business lost during this year’s COVID-19-driven closures of malls and stores.

Estimates from Adobe Analytics showed this year’s conclusion to Thanksgiving weekend promotions would come in between $10.8 billion and $11.4 billion.

While that was down from an earlier estimate of as much as $12.7 billion, it still easily surpasses this year’s Black Friday figure of $9 billion, which was the strongest Black Friday online sales result to date, as well as last year’s Cyber Monday total of $9.4 billion.

Consumers are likely to keep up that spending too, said Taylor Schreiner, director of Adobe Digital Insights.

“While COVID-19, the elections and uncertainty around stimulus packages impacted consumer shopping behaviors and made this an unprecedented year in e-commerce, we expect to see continued, record-breaking e-commerce sales from now until Christmas,” Schreiner said in a statement.

Adobe said top-selling items included hoverboards, televisions from LG Electronics and Samsung Electronics, Apple Inc’s AirPods and watches and the Nintendo Switch.

Amazon, one of the biggest beneficiaries of the pandemic-induced shift away from physical stores, did not appear to have any major technical glitches during the day.

Bill Hon, 49, a cook in Crawfordsville, Indiana, said Amazon was still drawing his business despite offers from other firms.

“I go online a little bit and look around and do some comparison shopping, but Amazon pretty much beats everything,” he said.

Amazon alone has needed to add hundreds of thousands of staff to its rosters to meet demand for home delivery during the pandemic. Its third-quarter sales jumped 37% to $96.1 billion.

© 2020 Reuters. All Rights Reserved.

Let's block ads! (Why?)

Article From & Read More ( Cyber Monday set to be biggest online shopping day in US history - Reuters )
https://ift.tt/3mrHHCO
Business

Exxon Mobil steps back from plan to increase spending, preparing to slash assets book value - Fox Business

Exxon Mobil Corp. is retreating from a plan to increase spending to boost its oil and gas production by 2025 and preparing to slash the book value of its assets by up to $20 billion, as the struggling company reassesses its next decade.

Continue Reading Below

Stocks in this Article

XOMEXXON MOBIL CORPORATION

$38.13

-2.06 (-5.13%)

The Texas oil giant, which has lost more than $2.3 billion over the first three quarters of this year after the coronavirus wreaked havoc on fossil-fuel demand, released a reduced spending outlook Monday for the next five years. It now plans to spend $19 billion or less next year and $20 billion to $25 billion a year between 2022 and 2025. It had previously planned to spend more than $30 billion a year in capital expenditures through 2025.

EXXONMOBIL CEO WARNS OF JOB CUTS COMING FOR EMPLOYEES IN US, CANADA

Exxon also said it would stop investing in certain natural-gas assets and telegraphed a massive write-down of between $17 billion and $20 billion to come in the fourth quarter.

Signage at an Exxon Mobil Corp. gas station in Houston, Texas, U.S., on Wednesday, Oct. 28, 2020. Photographer: Callaghan O'Hare/Bloomberg via Getty Images

The cuts are a course correction for Chief Executive Darren Woods, who laid out a plan in 2018 to spend $230 billion to double profits and pump an additional one million barrels of oil and gas a day by the middle of the next decade. That plan proved ill-timed, especially after the pandemic caused oil prices to plummet this spring.

Exxon said Monday it would now double its profits by 2027 but released no specific target for increasing its oil and gas production. Exxon executives have said in recent months that the company is reassessing its production targets.

CLICK HERE TO READ MORE ON FOX BUSINESS

Mr. Woods said in a statement that the company is focused on improving its earnings and strengthening its balance sheet to manage future price swings and maintain its dividend, which costs Exxon about $15 billion a year.

Click for more at WSJ.com

Let's block ads! (Why?)

Article From & Read More ( Exxon Mobil steps back from plan to increase spending, preparing to slash assets book value - Fox Business )
https://ift.tt/2JvGtb8
Business

Zoom Video Communications Obliterates Quarterly Earnings Estimates - Deadline

Zoom Video Communications, perhaps the ultimate corporate poster child of Covid-19, posted another blockbuster quarter of financial results.

The videoconferencing specialist said its profit in the quarter ending October 31 came in at 99 cents a share, well ahead of Wall Street analysts’ consensus expectation for 76 cents. Revenue more than quadrupled to $777.2 million, far better than analysts’ forecast for $694 million.

Shares in Zoom finished the trading day at $478.36, up more than 1%, but then fell back 5% after the earnings results were released. The stock has rocketed more than 600% in 2020 as the company’s technology has become a bedrock of the pandemic operating environment for companies, schools and institutions of every stripe.

The start-up faces a number of established rivals, however. Microsoft, whose Teams offering competes with Zoom, recently ditched the 40-minute time limit on subscribers to the free tier. Teams is also planning to soon allow users to stay connected along with up to 300 other participants. Zoom has capped free meetings at 40 minutes for no more than 100 participants.

While Zoom stock has been a nearly constant gainer through the year, recent news about Covid-19 vaccines has rewarded shares in many traditional building blocks of the economy. In late October and early November, Zoom stock plunged more than 30% as some investors shifted their bets toward more proven companies leading the overall economic recovery.

Meta Marshall, an analyst with Morgan Stanley, expressed her view in a note to clients last week that Zoom’s stock will have plenty of upside even after remote work starts to decline. “While a vaccine does change the outlook for how many employees will be working from home by the end of 2021, it doesn’t change the fact that in 2020, most employees remain at home (at least for a good portion of the week),” she wrote.

Let's block ads! (Why?)

Article From & Read More ( Zoom Video Communications Obliterates Quarterly Earnings Estimates - Deadline )
https://ift.tt/2Vi2iOd
Business

Exxon Mobil cuts billions in capital spending as oil and gas prices remain low. - The New York Times

Exxon Mobil announced on Monday that it would significantly cut spending on exploration and production over the next four years and would write off up to $20 billion of investments in natural gas.

The company struggled to adapt as oil and gas prices tumbled this spring when the coronavirus pandemic took hold. While oil prices have recovered somewhat in recent months, they remain much lower than they were at the start of the year.

The company said it was removing gas projects from its plans in Appalachia, the Rocky Mountains, Oklahoma, Texas, Louisiana, Arkansas, Canada and Argentina.

Darren Woods, Exxon Mobil’s chief executive, said in a statement that the moves were designed to “improve earnings power and cash generation, and rebuild balance sheet capacity to manage future commodity price cycles while working to maintain a reliable dividend.”

Exxon’s board of directors accepted a proposal by management to slash capital expenditures to between $16 billion and $19 billion next year, down from $23 billion in 2020. This year’s capital expenditures had already been reduced from a planned budget of $33 billion, as the company slowed projects in Africa and the Permian Basin in New Mexico and West Texas.

The company said capital spending would be limited to between $20 billion and $25 billion annually through 2025.

In 2010, Exxon Mobil acquired XTO Energy and its natural gas assets for more than $30 billion, just as gas prices were peaking. Over the next decade, the shale boom flooded the market with cheap gas.

Exxon Mobil had previously resisted writing down assets by large amounts. Several of the largest oil companies have recently written down assets, including Royal Dutch Shell by up to $22 billion, BP by more than $17 billion and Chevron by $10 billion.

But Exxon has fared worse than other major oil companies during the pandemic. It was removed from the Dow Jones industrial average in August and has suffered three consecutive quarterly losses. It recently said it would cut 14,000 jobs, or 15 percent of its global work force.

Exxon’s stock, which is down more than 40 percent over the past year, is back to where it was in 2003. Company executives continue to express confidence about the future because Exxon is producing more oil and gas in the Permian Basin and in the offshore waters of Guyana and Brazil. The company has also committed to maintaining its dividend, which yields more than an 8 percent return on its share price.

Let's block ads! (Why?)

Article From & Read More ( Exxon Mobil cuts billions in capital spending as oil and gas prices remain low. - The New York Times )
https://ift.tt/3qg4aoR
Business

Tesla Stock Will Be Added to S&P 500 All at Once. Expect Volatility Tomorrow. - Barron's

Tesla bulls got another bit of good news Monday evening. Tesla is going into the S&P 500 all at once, at its full weighting, on Dec. 21. Tesla stock is up in after hours trading. Investors should expect more big moves from the stock, up and down, in coming days.

Tesla (ticker: TSLA) is the most valuable company to ever be added to the S&P 500. That creates a unique problem for the S&P 500 index funds. They have an unusually large amount of stock to purchase because of Tesla’s massive $538 billion market capitalization.

...

Let's block ads! (Why?)

Article From & Read More ( Tesla Stock Will Be Added to S&P 500 All at Once. Expect Volatility Tomorrow. - Barron's )
https://ift.tt/36tnVBD
Business

Tony Hsieh Used to Ask a Really Weird Question at Zappos, and It's Definitely Worth Remembering - Inc.

I hadn't even gotten out of bed Saturday when I saw the news that Tony Hsieh, the former CEO and driving force behind Zappos, had died. 

I had two immediate thoughts:

First, sadness. Hsieh was only 46, and that's simply too young. 

Second, bemusement, as a single word popped into my head, and I realized it's probably forever neurologically associated with his name.

That word was "weird."

It comes in part from a question Hsieh used to ask during job interviews at Zappos: "On a scale of 1 to 10, how weird are you?"

He explained his reasoning a decade ago. "If you're a 1, you're probably a little bit too strait-laced for us," Hsieh told Adam Grant. "If you're a 10, you might be too psychotic for us. It's not so much the number; it's more seeing how candidates react to a question."

Hsieh had a lot of influence on aspiring entrepreneurs and leaders, especially for someone taken at a fairly early age. And as I went about my day Saturday, he kept coming up.

I took my daughter to the playground, and I chatted with another 40-something dad. Our conversation turned to Hsieh, and this other dad reminded me that Zappos had a policy that offered $1,000 to new employees to quit.

It was all about finding fit and culture and happiness: I mean, if you're willing to take $1,000 to leave a new job, it's probably better for all involved that you do so.

As someone who once quit a job after 1 day and went quasi-viral for it, that resonated with me. So, I wrote about the 2-word policy, as part of Hsieh's legacy.

Nearly 1 million people read it and many of them wrote to me about it. It's gratifying to have contributed some small thing to his memory, and to have highlighted that legacy.

But still, I want to hold up "weirdness."

Hsieh was roughly my contemporary -- again, probably part of why his death at age 46 hit me so hard. And when we were growing up, "weird" wasn't really a compliment. It was the G-rated version of insults that grade school bullies used on the kids they tormented.

Hsieh wasn't alone in redeeming "weirdness," but it really was part of the culture he sought to create at Zappos.

It was right up there in the company's core values: "Core Value #3: Create Fun & A Little Weirdness."

When Amazon bought Zappos in 2010, Hsieh wrote to reassuranace employees that Amazon wanted to "continue to build the Zappos culture in our own unique way," and added: "I think 'unique' was their way of saying 'fun and a little weird.' :)" 

But "weird" is still the word. It's how his friend, the investor Chris Sacca paid tribute to him Saturday: "beautifully weird."

And it's wrapped up in how other friends and admirers remembered him: "eccentric" and "a man of contradictions" -- a near-billionaire who built and lived in a trailer park in Las Vegas, and who kept a pet alpaca and wore a "sky-high mohawk" at times. 

"He loved making other people happy, but I think he was also always trying to solve that puzzle for himself," his friend, the journalist turned entrepreneur Sarah Lacy, told a newspaper. "I'm not sure how successful he was at it, to be honest."

There's some poignant irony to that observation, since Hsieh was very interested in what he called "the science of happiness," and literally called his best-selling 2010 book, Delivering Happiness.

Frankly, it's a problem for many entrepreneurs, especially the most successful ones.

The weirdness that leads you to look at the world a different way, and to see possibilities, can make it difficult to find contentment.

Many entrepreneurs wouldn't trade it, but there's a cost. So, you embrace whatever it is that makes you a bit weird, and you look for it in other people. Hopefully, you use it to build something, and to leave a legacy.

Someone once said that people die three times: when their body stops working, when they're buried, and after the last time anyone says their name.

I thought about that on the anniversary of a good friend's death. And I thought about it when I realized that two middle-aged guys who never met Hsieh were sitting in a park in New Jersey Saturday, talking about part of his legacy.

So here's to Tony Hsieh, the "beautifully weird" CEO, and to imitating the best parts of what he left behind.

And to remembering: Tony Hsieh, Tony Hsieh, Tony Hsieh.

The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.

Let's block ads! (Why?)

Article From & Read More ( Tony Hsieh Used to Ask a Really Weird Question at Zappos, and It's Definitely Worth Remembering - Inc. )
https://ift.tt/2KWq9kz
Business

Dow Jones Futures: Tesla Rallies On S&P 500 Update; Zoom Video Falls On Earnings; Apple, AMD Lead Stock Market Rally - Investor's Business Daily

Dow Jones futures rose late Monday, along with S&P 500 futures and Nasdaq futures. The stock market rally retreated Monday but came off lows, especially the Nasdaq, fueled by gains in Apple (AAPL), Moderna (MRNA) and AMD stock.

X

After the close, Zoom Video Communications (ZM) reported better-than-expected results and upside guidance. But Zoom Video stock fell solidly overnight. Meanwhile, Tesla stock rebounded overnight. The S&P 500 index will add Tesla (TSLA) in one fell swoop before Dec. 21, S&P Dow Jones Indices announced late Monday. Tesla stock reversed lower from a record high during the regular session. Moderna stock kept soaring.

Tesla and Zoom Video stock are two of the biggest 2020 winners, up 578% and 603%, respectively as of Monday's close. MRNA stock is 681% year to to date.

In Monday's session, Apple stock flashed an early buy signal, while Advanced Micro Devices (AMD) broke out. Apple chipmaker Qorvo (QRVO) also cleared a buy point.

Chinese stocks struggled on a variety of factors, including a looming House vote on legislation that could lead to delistings from U.S. markets. Fraud allegations vs. EV maker Kandi Technologies (KNDI) didn't help. E-commerce giants JD.com (JD), Pinduoduo (PDD) and Alibaba (BABA) suffered significant losses. Tesla electric car rivals Nio (NIO), Xpeng Motors (XPEV) and Li Auto (LI) also retreated.

JD.com stock, Pinduoduo, AMD and Tesla are on IBD Leaderboard. Apple stock is on the Leaderboard watchlist. AMD and Tesla stock are on SwingTrader. AMD stock is on the IBD 50.

Dow Jones Futures Today

Dow Jones futures rose 0.6% vs. fair value. S&P 500 futures climbed 0.7%. Nasdaq 100 futures advanced 0.8%.

Remember that overnight action in Dow futures and elsewhere doesn't necessarily translate into actual trading in the next regular stock market session.


Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live.


Coronavirus News

Coronavirus cases worldwide reached 63.58 million. Covid-19 deaths topped 1.47 million.

Coronavirus cases in the U.S. have hit 13.91 million, with deaths above 274,000.

The Moderna coronavirus vaccine is 94.1% effective, the biotech said early Monday. Notably, it's 100% effective in preventing serious Covid-19 cases. Moderna (MRNA) filed for FDA approval, a few days after Pfizer (PFE)] and BioNTech (BNTX) filed with the FDA for their 95%-effective coronavirus vaccine.

Moderna stock spiked 20% Monday, capping a 126% explosion in November. MRNA stock kept soaring overnight, tacking on 7%.

BioNTech leapt 13%, also to a new high. Pfizer rose 2.9%.

Stock Market Rally

U.S. Stock Market Today Overview

Index Symbol Price Gain/Loss % Change
Dow Jones (0DJIA) 29643.97 -266.40 -0.89
S&P 500 (0S&P5) 3621.82 -16.53 -0.45
Nasdaq (0NDQC ) 12198.74 -7.11 -0.06
Russell 2000 (IWM) 181.30 -3.07 -1.67
IBD 50 (FFTY) 39.50 +0.18 +0.46
Last Update: 4:22 PM ET 11/30/2020

The stock market rally had a down day, but the Nasdaq was resilient while leading stocks did well overall.

The Dow Jones Industrial Average lost 0.9% in Monday's stock market trading. The S&P 500 index sank 0.5%. The Nasdaq composite lost just a fraction, after falling more than 1% in morning action.

For the month, the Dow Jones soared 11.9%, the S&P 500 10.8% and the Nasdaq 11.8%.

Some highflying IPOs came under pressure Monday, though they generally closed with modest losses or even reversed higher.

Growth stocks overall fared well. Among the best ETFs, the Innovator IBD 50 ETF (FFTY) rose 0.5%. The iShares Expanded Tech-Software Sector ETF (IGV) climbed 0.45%. The VanEck Vectors Semiconductor ETF (SMH) popped 1.1%, with AMD stock a notable contributor.

Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.

Zoom Video Earnings

Zoom Video earnings shot up 1,000% to 99 cents a share, with revenue up 366.5% to $777.19 million. Analysts expected Zoom Video earnings of 76 cents on revenue of $693.4 million.

The videoconferencing leader guided higher for Q4 and for 2021

However, Zoom Video stock fell 5% overnight. Shares of the huge 2020 winner rose 1.4% to 478.36 on Monday, reclaiming the 50-day line.

AMD Stock

AMD stock jumped 6.3% to 92.66 in heavy volume Monday, breaking out powerfully from an 88.82 buy point from a double-bottom base.

Shares had already flashed some buy signals, closing above an 87.15 early entry on Friday.

CEO Lisa Su said during a Credit Suisse conference that AMD sees Q1 sales trending "a little bit better" than normal seasonality, suggesting some upside.

Qorvo Stock

Qorvo stock rose 4.4% to 156.68, clearing the 154.53 buy point from a three-weeks-tight pattern. Investors could have started buying QRVO stock as it moved above 152.70, topping last week's high.

The chipmaker is benefiting from momentum in 5G wireless, including the new Apple iPhone. Qorvo was an IBD Stock Of The Day last week.

Qualcomm (QCOM), another 5G and Apple chipmaker, rose 2.3% to 147.17, working on a four-weeks-tight entry with an official buy point of 153.43, according to MarketSmith analysis. Investors probably could start to nibble on QCOM stock here as it peeks above a short trend line. Qualcomm stock was Monday's Stock Of The Day.

Apple Stock

Giving a boost to Qualcomm and Qorvo stock, Apple stock rose 2.1% to 119.05, though it backed off an intraday high of 120.97.

Loop Capital upgraded Apple to a buy with a 131 price target, expecting upside to sales forecasts for the iPhone and other products and services. Morgan Stanley tapped the iPhone maker as a strong 5G play.

Shares are rebounding from their 50-day moving average, though the official buy point is 138.08. Early entries of 125.49 and 122.09 are closer in sight. Apple stock did cross a trend line starting from the Oct. 13 high, essentially closing right on that line.

An aggressive investor could start an AAPL stock position here, then perhaps add more shares as it clears the 122.09 and 125.49 levels and finally the 138.08 buy point.

Apple stock has slightly lagged the broader market for the past few months. If the tech giant, once again above a $2 trillion market cap, can wake up, it would add real momentum to the major indexes.

China Stocks

The U.S. House will take up legislation this week to require foreign companies listed on U.S. markets to face U.S. audits, or face delisting after a few years. It's directed at Chinese stocks, with Beijing barring U.S. audits of China-based companies.

Regulators are signaling that an Ant Group IPO may not happen until 2022, following the last-minute suspension of the blockbuster IPO from the Alibaba-tied payments giant.

Alibaba stock fell 4.75% on Monday, continuing to struggle as the e-commerce and payments giant seems to be the focus of Beijing's ire. But JD.com stock fell 4.5%, with Pinduoduo stock down 3.6%.

Kandi Technologies tumbled 28% after short-seller Hindenburg Research accused the Chinese EV maker of fraudulent sales. The resurgence of China accounting fraud claims and admissions has added to calls for closer oversight of Chinese companies.

Nio stock sank 6.4%. Li Auto and Xpeng stock lost nearly 9%.

Nio, Li Auto and Xpeng Motors will likely release November sales figures over the next week or so. Overall China EV production and sales, including trade group figures for Tesla, will probably come next week.

Tesla Stock Jumps On Latest S&P 500 News

Tesla stock rose 4% overnight after the S&P Dow Jones Indices' decision to add the EV maker to the S&P 500 index in one go. Because of Tesla's huge market cap, the committee had mulled splitting the stock's entry into two tranches.

Tesla stock has skyrocketed since the announcement that Tesla will join the S&P 500 before the open on Dec. 21.

Meanwhile, Tesla got China's official green light on Monday to sell the Model Y from its Shanghai plant, as expected.

Tesla stock briefly rose to a new high of 607.80 soon after Monday's open before reversing for a 3.1% decline to 567.30.

Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.

YOU MAY ALSO LIKE:

Why This IBD Tool Simplifies The Search For Top Stocks

Best Growth Stocks To Buy And Watch

IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today

Let's block ads! (Why?)

Article From & Read More ( Dow Jones Futures: Tesla Rallies On S&P 500 Update; Zoom Video Falls On Earnings; Apple, AMD Lead Stock Market Rally - Investor's Business Daily )
https://ift.tt/3g08wvG
Business

U.S. Shoppers Might Spend $13 Million Per Minute During Cyber Monday Peak - NPR

People shop at Macy's in New York on Black Friday, Nov. 27. Kena Betancur/AFP via Getty Images

Kena Betancur/AFP via Getty Images

U.S. shoppers are on track to spend more than $755 billion during the holiday shopping season in what's expected to be a new sales record despite the coronavirus recession.

In fact, this year's Cyber Monday promises to become the largest online sales day in history. During the peak hour of 8 pm to 9 pm Pacific, shoppers could spend $13 million per minute, according to Adobe Digital Insights, which tracks online spending.

Health officials have recommended against spending time in crowded stores as coronavirus cases surge yet again across the country, with tens of thousands of people hospitalized.

But shoppers say they are drawn by discounts — and by the desire to celebrate and feel special.

Over the weekend, top online purchases included Star Wars, Nerf and Paw Patrol toys, Apple AirPods and Watches and various video games, according to Adobe. Other hot items included air fryers, Lego sets, lounge clothes. Adobe also says sales of chess-related items tripled this month thanks to the Netflix sensation The Queens Gambit.

The National Retail Federation finally released its delayed holiday shopping forecast last week, predicting that retail sales will grow between 3.6% and 5.2% to their highest level ever. The trade group says shoppers will spend on average $998 on gifts, food, decorations and other holiday items.

Online stores are by far the winners of this shopping spree. And the season is seeing a huge growth in popularity of curbside pick-up, with shoppers driving up to stores but avoiding indoor public spaces.

Let's block ads! (Why?)

Article From & Read More ( U.S. Shoppers Might Spend $13 Million Per Minute During Cyber Monday Peak - NPR )
https://ift.tt/3fQEIl7
Business

Topshop owner Arcadia files for bankruptcy - CNN

The company, which also owns Miss Selfridge and Dorothy Perkins, has entered administration, which is roughly equivalent to Chapter 11 bankruptcy protection in the United States, according to a statement from Deloitte, which will oversee the process. Deloitte said no redundancies were being announced Monday and stores would continue to operate.
"This is an incredibly sad day for all of our colleagues as well as our suppliers and our many other stakeholders. The impact of the Covid-19 pandemic including the forced closure of our stores for prolonged periods has severely impacted on trading across all of our brands," Ian Grabiner, CEO of Arcadia, said in the statement.
The bankruptcy filing comes as the UK economy grapples with a growing unemployment crisis and its worst recession in more than 300 years.
Major clothing retailers, including Marks & Spencer (MAKSY) and Selfridges, have announced sweeping job cuts as a result of the pandemic, which closed stores for months and accelerated a shift to online shopping that was already hurting high street stores.
Arcadia, which cut 500 head office jobs earlier this year, was struggling even before the pandemic hit. The group narrowly avoided bankruptcy in June 2019 after it managed to renegotiate debt repayments and restructure the business. It closed some 50 stores across the United Kingdom and Ireland and all 11 of its Topshop and Topman stores in the United States.
Arcadia's demise will further tarnish the reputation of its owner Phillip Green, once deemed one of Britain's most successful retail entrepreneurs who was knighted in 2006 for services to the industry. A cloud of controversy has surrounded Green in recent years, following the collapse in 2016 of department store BHS, which he owned for 15 years before selling it reportedly for £1 in 2015.
After BHS went bankrupt, UK lawmakers said in a report that Green had weakened the company by extracting hundreds of millions of pounds for the benefit of his family, and voted to strip him of his knighthood. Under pressure from regulators, Green eventually coughed up £363 million ($484 million) to safeguard the pensions of former employees.
Frasers Group, the company led by British retail billionaire Mike Ashley that owns brands such as Sports Direct and Slazenger, said Monday that Arcadia had declined a "lifeline loan" of up to £50 million ($66.7 million) from the company. "Frasers Group were not given any reasons for the rejection, nor did Frasers Group have any engagement from Arcadia before the loan was declined," it said in a statement.
According to senior apparel analyst at GlobalData, Chloe Collins, Arcadia has "been losing relevance for years," investing too little in digital offerings and losing market share to online rivals such as Boohoo and Asos (ASOMY). "The best chance for any of its brands is if they are split out," she told CNN Business. Boohoo, Next (NXGPY) and Marks & Spencer could be among potential interested buyers, Collins added.
Arcadia said Friday it was planning to reopen stores in England and the Republic of Ireland when lockdown restrictions are eased on Wednesday. The company operates about 550 sites in Britain and Europe, and sells its Topshop Topman brands in Nordstrom stores in the United States.

Let's block ads! (Why?)

Article From & Read More ( Topshop owner Arcadia files for bankruptcy - CNN )
https://ift.tt/36oCTsv
Business

Stock market news live updates: Dow futures open slightly higher after best month since 1987 - Yahoo Finance

Stock futures began the overnight session slightly higher Monday evening, reversing some of the regular session’s declines.

Equities are set to kick off the final month of 2020 on the heels of a record month, during which each of the three major indices made fresh record highs, and the Dow posted its biggest monthly gain since January 1987 with an advance of nearly 11.9%. In the S&P 500, the energy, financials and industrials sectors led the index’s 10.8% rise, as traders rotated back into many of the names that had been beaten down the hardest earlier on during the pandemic.

Many analysts believe equities will continue to ride the wave of vaccine-related optimism from November into December, after each of Pfizer (PFE), Moderna (MRNA) and AstraZeneca (AZN) reported promising efficacy data for their respective COVID-19 vaccine candidates. Developments in the race to create an inoculation against the coronavirus helped stocks shake off volatility from earlier on in the month.

“In early November, when we saw the VIX (^VIX) spike to 40, it was because of COVID. It was because of surging cases, not just here in the states but really across the world,” Alfred Eskandar, Salt Financial President, told Yahoo Finance on Monday. “And conversely, you see the VIX coming down to the levels where it is today, by nearly half, also because of positive news on the vaccine. So the market is very, very sensitive to what is happening with COVID.”

“There's definitely a lot of reasons to be exposed to equities now and into the near future,” he added. “The optimistic viewpoint is certainly alive and well.”

Other analysts echoed this optimism. Fundstrat Managing Partner Tom Lee said in a note Monday he believed the S&P 500 would end 2020 at 3,800, implying another about 5% upside for the index.

“We don't see how stocks suddenly weaken in this final month,” Lee said. “Granted, the risk is that this is a consensus view, but we are in a seasonally strong period for equities.”

But while equities melted higher in November, risks to the U.S. economy still remain at least in the near-term. In prepared remarks Monday for an appearance before Congress on Tuesday, Federal Reserve Chair Jerome Powell reiterated that the economic growth will likely continue to be capped “until people are confidence that it is safe to reengage in a broad range of activities.”

“Recent news on the vaccine front is very positive for the medium term. For now, significant challenges and uncertainties remain, including timing, production and distribution, and efficacy across different groups,” he said. “It remains difficult to assess the timing and scope of the economic implications of these developments with any degree of confidence.”

6:03 p.m. ET Monday: Stock futures open slightly higher

Here were the main moves in markets, as of 6:03 p.m. ET Monday evening:

  • S&P 500 futures (ES=F): 3,628.75, up 5.5 point or 0.15%

  • Dow futures (YM=F): 29,641.00, up 12 points or 0.04%

  • Nasdaq futures (NQ=F): 12,328.00, up 51 points or 0.42%

A trader wearing a protective face mask walks, as the global outbreak of the coronavirus disease (COVID-19) continues, outside the New York Stock Exchange (NYSE) in the financial district of New York, U.S., November 19, 2020. REUTERS/Shannon Stapleton
A trader wearing a protective face mask walks, as the global outbreak of the coronavirus disease (COVID-19) continues, outside the New York Stock Exchange (NYSE) in the financial district of New York, U.S., November 19, 2020. REUTERS/Shannon Stapleton

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and reddit.

Find live stock market quotes and the latest business and finance news

For tutorials and information on investing and trading stocks, check out Cashay

Let's block ads! (Why?)

Article From & Read More ( Stock market news live updates: Dow futures open slightly higher after best month since 1987 - Yahoo Finance )
https://ift.tt/3mpcOPF
Business

Here are the major retailers offering big Cyber Monday deals - Fox Business

Even though deals have been available online for weeks, shoppers are expected to hit their favorite retail websites in record numbers this Cyber Monday.

Continue Reading Below

While some retailers are offering deals all day, others will be offering up a slate of discounts all week long as shoppers increasingly hunt for their gifts online rather than in person this season.

On Monday alone, shoppers are projected to spend a record-breaking $10.8 billion to $12.7 billion, representing a 15% to 35% increase in spending since last year, according to Adobe Analytics.

Here are the major retailers offering Cyber Monday discounts:

BLACK FRIDAY HITS RECORD $9B IN US CONSUMER SPENDING

Amazon 

Although Amazon had its own shopping holiday -- Prime Day -- in October, the company is not short of deals for Cyber Monday.

As of Monday, the company has upward of 1,000 active deals on its website, which were broken up by category. The retailer also noted a separate section for small and independent businesses which make up more than 50% of the items sold on Amazon.

Some of Amazon's "deals of the day" include 25% off Samsung TVs and up to 20% off select HP monitors, laptops and desktops.

Amazon shoppers can also get up to 40% off on smart home products, up to 30% off on Lacoste apparel, and up to 15% off on PC gaming laptops, desktops and monitors.

Best Buy

Best Buy is also offering a range of discounts on its most popular electronics with some smart TVs seeing a more than $500 reduction.

Its featured deals of the day include various Samsung smart TVs with discounts ranging from $50 to $600 off. The retailer is also offering a $30 reduction on Amazon's Echo and a $100 reduction for some HP laptops.

Consumers can also nab Sony noise-canceling headphones for under $280, down from the original price of $350.

TARGET OFFERS FULL WEEK OF CYBER SALES TO SHOPPERS SHUNNING IN-STORE PURCHASES DURING CORONAVIRUS

Meanwhile, consumers can save $90 on select Powerbeats Pro wireless earphones as well as upward of $100 on select Apple Macbook Pro models.

Staples 

Rather than just one day, Staples is offering a full week of savings. Consumers can save up to $100 off on select computers while paying as little as $17.99 for select streaming and smart home devices.

Some monitors are on sale for $90 while some gaming and office chairs are on sale for roughly $60.

Target 

Like Staples, Target is also offering a full week of deals that will run through Dec. 5.

The big-box retailer is offering up savings including up to 50% off on select furniture, up to 30% off on home decor, up to 40% off on select bedding and bath products as well as 25% off select beauty products.

Consumers can also save $50 on the Apple Watch Series 6.

However, on Monday only, shoppers can save an extra 15% on select items ranging from video games to kitchen supplies and cold weather gear.

Like Best Buy, the retailer is also offering flash deals throughout the day for anything from electronics to cookware.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Walmart

The retail behemoth has nearly 2,000 products on sale Monday ranging from toys and electronics to fashion, beauty and home essentials. Many of the products are also eligible for next-day delivery, free two-day shipping or in-store pickup.

The deals include roughly $100 off Beats Studio3 Wireless Noise Cancelling Headphones. Consumers can also get a Lenovo Chromebook for $160 or a 60-inch Smart LED TV for just under $300.

Clothing and accessories are up to 70% off. Select diamond stud earnings dropped in price to $80.

Meanwhile, family pajamas are up to 50% off and clothing is up to 60% off.

CLICK HERE TO READ MORE ON FOX BUSINESS

Let's block ads! (Why?)

Article From & Read More ( Here are the major retailers offering big Cyber Monday deals - Fox Business )
https://ift.tt/2KU2vVQ
Business

Congress under pressure to pass COVID-19 stimulus, has brief window - Business Insider - Business Insider

Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine - The New York Times

The drugmaker Moderna said it would apply on Monday to the Food and Drug Administration to authorize its coronavirus vaccine for emergency use.

The first injections may be given as early as Dec. 21 if the process goes smoothly and approval is granted, StĂ©phane Bancel, the company’s chief executive, said in an interview.

Moderna’s application is based on data that it also announced on Monday, showing that its vaccine is 94.1 percent effective, and that its study of 30,000 people has met the scientific criteria needed to determine whether the vaccine works. The finding from the complete set of data is in line with an analysis of earlier data released on Nov. 16 that found the vaccine to be 94.5 percent effective.

The new data also showed that the vaccine was 100 percent effective at preventing severe disease from the coronavirus. The product was developed in collaboration with government researchers from the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases.

Mr. Bancel said the company was “on track” to produce 20 million doses by the end of December, and 500 million to a billion in 2021. Each person requires two doses, administered a month apart, so 20 million doses will be enough for 10 million people.

Moderna is the second vaccine maker to apply for emergency use authorization; Pfizer submitted its application on Nov. 20. Pfizer has said it can produce up to 50 million doses this year, with about half going to the United States. Its vaccine also requires two doses per person.

The first shots of the two vaccines are likely to go to certain groups, including health care workers, essential workers like police officers, people in other critical industries and employees and residents in nursing homes. On Tuesday, a panel of advisers to the Centers for Disease Control and Prevention will meet to determine how to allocate initial supplies of vaccine.

The hopeful news arrives at a particularly grim moment in the U.S. health crisis. Coronavirus cases have surged and overwhelmed hospitals in some regions, and health officials have warned that the numbers may grow even worse in the coming weeks because of Thanksgiving travel and gatherings. In November alone, there have been more than four million new cases and 25,500 deaths in the United States.

Over all, about 13.3 million Americans have contracted the virus, and more than 265,900 have died. Worldwide, there have been nearly 62 million cases and almost 1.5 million deaths.

More than 70 coronavirus vaccines are being developed around the world, including 11 that, like Pfizer’s and Moderna’s vaccines, are in large-scale trials to gauge effectiveness.

One of those is made by AstraZeneca, which announced positive but puzzling preliminary results on Nov. 23: Its vaccine was 90 percent effective in people who received a half dose and then a full one, but 62 percent effective in those who received two full doses. Researchers are waiting for more data.

Moderna’s application for emergency use authorization will include data from its Phase 3 study of 30,000 people. The application, several hundred pages long, will also include several thousand pages of additional data.

F.D.A. scientists will examine the information, and the application is likely to undergo a final review on Dec. 17 by a panel of expert advisers to the agency, Mr. Bancel said, adding that he expected the advisers to make a decision within 24 to 72 hours. The F.D.A. usually follows the recommendations of its advisory panels.

Officials at Operation Warp Speed, the government’s program to accelerate vaccine development, have said vaccinations could begin within 24 hours after the F.D.A. grants authorization.

Mr. Bancel said that Moderna had not yet begun shipping vaccines across the country, and would not do so until the emergency authorization is granted.

The government has arranged to buy vaccines from both Moderna and Pfizer and to provide it to the public free of charge. Moderna has received a commitment of $955 million from the U.S. government’s Biomedical Advanced Research and Development Authority for research and development of its vaccine, and the United States has committed up to $1.525 billion to buy 100 million doses.

Both Moderna’s and Pfizer’s vaccines use a synthetic form of genetic material from the coronavirus called messenger RNA, or mRNA, to program a person’s cells to make many copies of a part of the virus. That viral fragment sets off alarms in the immune system and trains it to recognize and attack if the real virus tries to invade.

No mRNA vaccine has reached the market before, and the candidates from Pfizer and Moderna have faced considerable skepticism from scientists and a wary public.

But the strong results from both vaccines have begun to quash the doubts.

So far, neither vaccine has had serious side effects, but many recipients have had headaches, mild fevers, fatigue, joint and muscle aches and sore arms for a day or two.

Of the 30,000 people in the Moderna study, half were vaccinated and half received placebo shots of salt water; neither the participants nor their doctors knew who got what. Then, researchers monitored the participants to see who contracted the coronavirus, and watched for side effects.

To determine statistically whether the vaccine was effective, a total of 151 cases of Covid-19 were needed.

Because the coronavirus has been surging in the United States, Moderna wound up with 196 cases — 185 in the placebo group, and 11 in the vaccinated group, meaning that the vaccine was 94.1 percent effective at preventing Covid-19.

Thirty participants had severe cases, all in the placebo group. One died.

Mr. Bancel said he considered the statistics about prevention of severe disease the most important data from the study.

“This is why I think this vaccine is going to be a game-changer,” he said. The vaccine will reduce hospitalizations and deaths, he added, “and I hope get this country back to its pre-pandemic state.”

Moderna said it was also seeking authorization to market its vaccine in Europe, Canada, Britain, Israel and Singapore.

Let's block ads! (Why?)

Article From & Read More ( Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine - The New York Times )
https://ift.tt/2VjrPq4
Business

Cyber Monday 2020: 3 under-the-radar winners amid a limp start to the holiday shopping season - Yahoo Finance

TipRanks

Billionaire Israel Englander Pours Money Into 2 “Strong Buy” Stocks

Following the wild ride that was 2020, where does the market go from here? Major strides have been made in the COVID-19 vaccine race, yet the near-term picture remains unclear, blurred by the virus’ resurgence and the stimulus stalemate on Capitol Hill.In times like these, the investing greats can serve as a source of inspiration, namely billionaire Israel “Izzy” Englander.Who exactly is Englander? The legend, who started trading stocks when he was in high school, began his career interning at investment firm Oppenheimer, later going on to purchase a seat on the American Stock Exchange, where he would serve as a floor broker, trader and specialist.In 1989, along with Ronald Shear, Englander founded hedge fund Millennium Management. As evidence of his stellar track record, the guru took the $35 million the fund was started with and turned it into over $40 billion in assets under management. With his personal net worth clocking in at $7.2 billion, it’s no wonder Wall Street pays attention when Englander makes a move.Bearing this in mind, our focus shifted to Millenium’s most recent 13F filing, which discloses the stocks the fund snapped up in the third quarter. Locking in on two tickers in particular, TipRanks’ database revealed that both names score a “Strong Buy” analyst consensus. What’s more, the analyst community sees massive upside potential in store for each.G1 Therapeutics (GTHX)Bringing a deep understanding of the biology of cancer and extensive drug discovery experience to the table, G1 Therapeutics works to develop therapies that could potentially improve the lives of patients battling the deadly disease. Ahead of a key regulatory decision, the Street is pounding the table on this name.During the third quarter, Englander and Millennium picked up a new stake in GTHX. Pulling the trigger on 555,937 shares, the value of the holding comes in at $6,421,000.Turning to the analyst community, Needham’s Chad Messer tells clients that he has high hopes ahead of the February 15 PDUFA date for trilaciclib, its therapy designed to improve outcomes for cancer patients treated with chemotherapy. The therapy’s NDA was accepted in August for Priority Review based on results from three randomized clinical studies in small cell lung cancer (SCLC), with the FDA indicating that it doesn’t plan on holding an advisory committee (AdComm) meeting.As trilaciclib is the first CDK4/6 inhibitor to be used to treat chemo-induced bone marrow toxicity, Messer argues that the lack of an AdComm is “meaningful.” Expounding on this, he stated, “We believe this reflects the agency's appreciation of the unmet need, comfort with the safety profile of the CDK4/6 class, and efficacy profile of trilaciclib.”GTHX will also focus on the inclusion of trilaciclib into NCCN guidelines. It should also be noted that a Phase 3 pivotal study evaluating the candidate in metastatic colorectal cancer (mCRC) is set to kick off by year end.Adding to the good news, GTHX and its partner, Boehringer Ingelheim, are preparing for the commercial launch of trilaciclib, with the companies covering approximately 2,500 treating oncologists and providing educational materials regarding the use of trilaciclib ahead of treatment and the benefits of multi-lineage preservation.If that wasn’t enough, the rintodestrant (its selective estrogen receptor degrader (SERD) in development for the treatment of estrogen receptor-positive (ER+) breast cancer) plus palbociclib combination study was able to wrap up enrollment earlier than expected, reflecting “the appeal of an all-oral treatment regimen during a global pandemic,” in Messer’s opinion. With a data readout slated for Q2 2021, the analyst believes a “positive readout could prove to be a significant value driver.”In line with his optimistic approach, Messer reiterated a Buy rating and $74 price target, indicating 417% upside potential. (To watch Messer’s track record, click here)Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the message is clear: GTHX is a Strong Buy. Given the $59 average price target, shares could rise 312% in the next year. (See GTHX stock analysis on TipRanks)Epizyme (EPZM)Also fighting the good fight against cancer, as well as against other serious diseases, Epizyme wants to find new treatments through novel epigenetic medicines. Even though the company faces headwinds with regard to its recent product launch, several members of the Street believe big things are in store.Millenium purchased 461,258 shares during the third quarter, with the buy reflecting a new position for the hedge fund. As for the value of the holding, it lands at $5,503,000.Writing for Wedbush, 5-star analyst David Nierengarten points out that the pandemic has limited oncologist visits, and therefore, Tazverik (the company's follicular lymphoma treatment) sales were lower than he expected. He points out that “the pandemic shifts the launch curve to an ‘incidence model’ rather than a prevalence model, as there is a limited patient pool to draw from if they are delaying office visits,” with patients waiting to seek treatment until they experience symptoms of progression.Additionally, although the launch is virtual and physician awareness is high, physicians are opposed to prescribing a new medication without examining the patient in person. That being said, Nierengarten remains optimistic about the therapy.“Despite these headwinds, Tazverik came close to meeting our estimates, and it is gaining market share, including seeing initial sales in second line. We expect more meaningful second line sales to begin in 2021, and have more gradually incorporated them into our launch curve,” the analyst explained.When it comes to the time on therapy, Nierengarten argues it’s too early to come to any conclusions. However, he highlights the fact that durability of response was relatively long and patients were treated past progression in the registration study. “Furthermore, the headwind against switching therapies turns into a tailwind of Tazverik maintenance once a patient is on therapy. This will likely contribute more meaningfully to 2H21 revenues and potential revenue outperformance,” he added.Summing it all up, Nierengarten commented, “At current levels, we believe investors are too negative on Tazverik’s potential and patience should be rewarded.”Based on all of the above, Nierengarten sides with the bulls, reiterating an Outperform rating and $27 price target. This target conveys his confidence in EPZM’s ability to climb 122% higher in the next year. (To watch Nierengarten’s track record, click here)Most other analysts echo Nierengarten’s sentiment. 3 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $23.25, the upside potential comes in at 91%. (See EPZM stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Let's block ads! (Why?)

Article From & Read More ( Cyber Monday 2020: 3 under-the-radar winners amid a limp start to the holiday shopping season - Yahoo Finance )
https://ift.tt/3g1BPhv
Business

S&P Global and IHS Markit to Merge in All-Stock Transaction Valuing IHS Markit at $44 Billion, Powering the Markets of the Future - PRNewswire

NEW YORK and LONDON, Nov. 30, 2020 /PRNewswire/ -- S&P Global (NYSE: SPGI) and IHS Markit (NYSE: INFO) today announced they have entered into a definitive merger agreement to combine in an all-stock transaction which values IHS Markit at an enterprise value of $44 billion, including $4.8 billion of net debt. The transaction brings together two world-class organizations, a unique portfolio of highly complementary assets in attractive markets and cutting-edge innovation and technology capability to accelerate growth and enhance value creation.

Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, each share of IHS Markit common stock will be exchanged for a fixed ratio of 0.2838 shares of S&P Global common stock. Upon completion of the transaction, current S&P Global shareholders will own approximately 67.75% of the combined company on a fully diluted basis, while IHS Markit shareholders will own approximately 32.25%.

S&P Global and IHS Markit's unique and highly complementary assets will leverage cutting-edge innovation and technology capability, including Kensho and the IHS Markit Data Lake, to enhance the customer value proposition and provide the intelligence customers need to make decisions with conviction. Serving a global customer base across financial information and services, ratings, indices, commodities and energy, and transportation and engineering, the pro forma company will provide differentiated solutions important to the workflows of many of the world's leading companies.

The transaction creates a pro forma company with increased scale, world-class products in core markets and strong joint offerings in high-growth adjacencies, including private assets, small and medium enterprises ("SME"), counterparty risk management, supply chain and trade and alternative data. Combined, the two companies will provide comprehensive solutions across data, platforms, benchmarks and analytics in ESG, climate and energy transition.

Douglas Peterson, President and Chief Executive Officer of S&P Global, will serve as CEO of the combined company. Lance Uggla, Chairman and Chief Executive Officer of IHS Markit, will stay on as a special advisor to the company for one year following closing.

"Through this exciting combination, we are able to better serve our markets and customers by creating new value and insights," said Mr. Peterson. "This merger increases scale while rounding out our combined capabilities, and accelerates and amplifies our ability to deliver customers the essential intelligence needed to make decisions with conviction. We are confident that the strengths of S&P Global and IHS Markit will enable meaningful growth and create attractive value for all stakeholders. We have been impressed by the IHS Markit team and look forward to welcoming the talented IHS Markit employees to S&P Global."

"This transaction is a win for both IHS Markit and S&P Global as we leverage our respective strengths in information, data science, research and benchmarks," said Mr. Uggla. "Our highly complementary products will deliver a broader set of offerings across multiple verticals for the benefit of our customers, employees and shareholders. Our cultures are well aligned, and the combined company will provide greater career opportunities for employees. We look forward to bringing together our teams to realize the potential of this combination."

Strategic Rationale – Powering the Markets of the Future

  • Greater scale and business mix: The transaction creates a combined business with increased scale and world-class products in core market segments. The combined company will have balanced earnings across major industry segments and a resilient portfolio, providing additional financial flexibility to pursue value-creating opportunities.
  • Creates strong offerings in high-growth adjacencies: The combined company will be differentiated in attractive high-growth adjacencies, including ESG, climate and energy transition, private assets and SME, counterparty risk management, supply chain and trade, and alternative data, which together represent $20 billion of total addressable market, growing at least 10% annually. As part of its ongoing commitment to remain on the cutting edge of technology and innovation, the combined company will continue to deploy well above $1 billion annually on technology.
  • Increased customer value proposition: The transaction brings together both companies' customer-first cultures and broadens their combined reach across client segments, workflows and use cases. The pro forma organization will serve diverse customer segments across financial services, corporates and governments with differentiated data and intelligence, including the potential to link and create novel insights from new data set combinations. S&P Global and IHS Markit's complementary product portfolios are expected to enable the combined company to serve new and expanded customer use cases in existing and new geographies.
  • Best-in-Class talent: The combined company will benefit from two best-in-class workforces with deep expertise and strong, complementary cultures focused on serving the global needs of customers. As a single organization, the collective workforce will benefit from expanded opportunities for career development and growth.

Financial Benefits – Strong Financial Profile and Outlook

  • Enhanced growth profile: The pro forma company will have 76% recurring revenue and expects to realize 6.5-8.0% annual organic revenue growth in 2022 and 2023, balanced across major industry segments.
  • Increased profitability: The combined company will target 200 basis points of annual EBITA margin expansion.
  • Attractive synergy opportunities and earnings accretion: The transaction is expected to be accretive to earnings by the end of the second full year post-closing. The combined company expects to deliver annual run-rate cost synergies of approximately $480 million, with approximately $390 million of those expected by the end of the second year post-closing, and $350 million in run-rate revenue synergies for an expected total run-rate EBITA impact of approximately $680 million by the end of the fifth full year after closing.  
  • Maintains strong balance sheet to pursue further growth: The combined company is expected to maintain a strong balance sheet and credit profile, with pro forma annual revenue of more than $11.6 billion. S&P Global intends to maintain a prudent and flexible capital structure and will target leverage of 2.0-2.5x EBITA, on an agency-adjusted basis.
  • Enhanced free cash flow generation to support attractive capital return: The combined company expects to generate annual free cash flow exceeding $5 billion by 2023, with a targeted dividend payout ratio of 20-30% of adjusted diluted EPS and a targeted total capital return of at least 85% of free cash flow between dividends and share repurchases. Both companies expect to maintain their current dividend policies until the close of the transaction.

Management and Board

Following closing, the Company will be headquartered in New York with a substantial presence in key global markets across North America, Latin America, EMEA and Asia Pacific.

The combined company is committed to retaining a strong, highly qualified and diverse Board that has the appropriate skills, knowledge and experience to oversee the company and its long-term strategic growth and performance. The combined company's Board of Directors will include the current S&P Global Board of Directors and four directors from the IHS Markit Board. Richard Thornburgh, current Chairman of S&P Global, will serve as Chairman of the combined company.

The leadership team will comprise senior leaders from both organizations. Ewout Steenbergen, Executive Vice President and Chief Financial Officer of S&P Global, will serve as Chief Financial Officer of the combined company.

The transition and integration of the combined company will be led by executives from both S&P Global and IHS Markit. The approach to integration planning will draw from the best practices of both companies to ensure continuity for customers, employees and other stakeholders.

Timing and Approvals

The transaction is expected to close in the second half of 2021, subject to, among other things, the expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, other antitrust and regulatory approvals, and other customary closing conditions. The transaction requires the approval of shareholders of both S&P Global and IHS Markit and is not subject to any financing conditions.

Advisors
Goldman, Sachs & Co. LLC is serving as lead financial advisor to S&P Global. Citi and Credit Suisse are also serving as financial advisors to S&P Global. Wachtell, Lipton, Rosen & Katz is serving as legal advisor to S&P Global. Morgan Stanley & Co. LLC is serving as lead financial advisor to IHS Markit. Barclays, Jefferies LLC and J.P. Morgan Securities LLC are also serving as financial advisors to IHS Markit. Davis Polk & Wardwell LLP is serving as legal advisor to IHS Markit.

Conference Call Details
The companies will hold a joint conference call today, November 30, 2020, at 8:15 a.m. EST / 1:15 p.m. GMT to discuss the details of this transaction. Additional information presented on the conference call may be made available on the Companies' Investor Relations Websites at http://investor.spglobal.com and http://investor.ihsmarkit.com.

Webcast Instructions:  The Webcast (audio and slides) will be available live and as an archived replay through S&P Global's Investor Relations website at http://investor.spglobal.com/Investor-Presentations and IHS Markit's Investor Relations website at https://investor.ihsmarkit.com. (Please copy and paste URL into Web browser.) The archived replay will be available beginning two hours after the conclusion of the live call and will remain available for one year.

Telephone Instructions:  The call begins at 8:15 a.m. EST. Please connect 10 minutes prior.

For callers in the U.S.:  (888) 603-9623
For callers outside the U.S.:  +1 (630) 395-0220 (long-distance charges will apply)
The numeric passcode is 589 7344

The recorded telephone replay will be available approximately two hours after the meeting concludes and will remain available until December 30, 2020.

For callers in the U.S.:  (888) 566-0708
For callers outside the U.S.:  +1 (203) 369-3622 (long-distance charges will apply). No passcode is required.

About S&P Global
S&P Global (NYSE: SPGI) is the world's foremost provider of credit ratings, benchmarks and analytics in the global capital and commodity markets, offering ESG solutions, deep data and insights on critical business factors. We've been providing essential intelligence that unlocks opportunity, fosters growth and accelerates progress for more than 160 years. Our divisions include S&P Global Ratings, S&P Global Market Intelligence, S&P Dow Jones Indices and S&P Global Platts. For more information, visit www.spglobal.com.

About IHS Markit
IHS Markit (NYSE: INFO) is a world leader in critical information, analytics and solutions for the major industries and markets that drive economies worldwide. The company delivers next-generation information, analytics and solutions to customers in business, finance and government, improving their operational efficiency and providing deep insights that lead to well-informed, confident decisions. IHS Markit has more than 50,000 business and government customers, including 80 percent of the Fortune Global 500 and the world's leading financial institutions. Headquartered in London, IHS Markit is committed to sustainable, profitable growth. For more information, visit www.ihsmarkit.com.

Forward-Looking Statements
This document contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, which are based on current expectations, estimates and projections about future business and operating results, the industry and markets in which S&P Global Inc. ("S&P Global") and IHS Markit Ltd. ("IHS Markit") operate and beliefs of and assumptions made by S&P Global management and IHS Markit management, involve uncertainties that could significantly affect the financial or operating results of S&P Global, IHS Markit or the combined company. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will, " "should," "may," "projects," "could," "would," "target," "estimates" or variations of such words and other similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature, but not all forward-looking statements include such identifying words.  Such forward-looking statements include, but are not limited to, projections of earnings, statements of plans for future operations or expected revenues, statements about the benefits of the transaction involving S&P Global and IHS Markit, including future financial and operating results and cost and revenue synergies, the combined company's plans, objectives, expectations and intentions. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to creating value for shareholders, benefits of the proposed transaction to shareholders, employees, customers and other constituents of the combined company, the outcome of contingencies, future actions by regulators, changes in business strategies and methods of generating revenue, the development and performance of each company's services and products, integrating our companies, cost savings, the expected timetable for completing the proposed transaction, general conditions in the geographic areas where we operate and our respective effective tax rates, cost structure, dividend policy, cash flows or liquidity — are forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in such forward-looking statements.  We can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. For example, these forward-looking statements could be affected by factors including, without limitation, risks associated with: (i) the satisfaction of the conditions precedent to consummation of the proposed transaction, including the ability to secure regulatory approvals on the terms expected, at all or in a timely manner; (ii) the ability of S&P Global and IHS Markit to obtain shareholder approval for the proposed transaction; (iii) uncertainty relating to the impact of the proposed transaction on the businesses of S&P Global and IHS Markit, including potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction and changes to existing business relationships during the pendency of the acquisition that could affect S&P Global's and/or IHS Markit's financial performance; (iv) the ability of S&P Global to successfully integrate IHS Markit's operations and retain and hire key personnel; (v) the ability of S&P Global to implement its plans, forecasts and other expectations with respect to IHS Markit's business after the consummation of the proposed transaction and realize expected synergies; (vi) business disruption following the proposed transaction; (vii) economic, financial, political and regulatory conditions, in the United States and elsewhere, and other factors that contribute to uncertainty and volatility, including the upcoming U.S. presidential transition, the United Kingdom's withdrawal from the European Union, natural and man-made disasters, civil unrest, pandemics (e.g., the coronavirus (COVID-19) pandemic (the "COVID-19 pandemic")), geopolitical uncertainty, and conditions that may result from legislative, regulatory, trade and policy changes associated with the current or subsequent U.S. administration; (viii) the ability of S&P Global and IHS Markit to successfully recover from a disaster or other business continuity problem due to a hurricane, flood, earthquake, terrorist attack, war, pandemic, security breach, cyber -attack, power loss, telecommunications failure or other natural or man-made event, including the ability to function remotely during long-term disruptions such as the COVID-19 pandemic; (ix) the impact of public health crises, such as pandemics (including the COVID-19 pandemic) and epidemics and any related company or governmental policies and actions to protect the health and safety of individuals or governmental policies or actions to maintain the functioning of national or global economies and markets, including any quarantine, "shelter in place," "stay at home," workforce reduction, social distancing, shut down or similar actions and policies; (x) the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; (xi) changes in debt and equity markets, including credit quality and spreads; (xii) demand for investment products that track indices and assessments, and trading volumes of certain exchange-traded derivatives; (xiii) changes in financial markets, capital, credit and commodities markets and interest rates; (xiv) the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (xv) the parties' ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; and (xvi) those additional risks and factors discussed in reports filed with the Securities and Exchange Commission (the "SEC") by S&P Global and IHS Markit from time to time, including those discussed under the heading "Risk Factors" in their respective most recently filed Annual Reports on Form 10-K and subsequent Quarterly Reports on Form 10-Q. While the list of factors presented here is considered representative, this list should not be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on S&P Global's or IHS Markit's consolidated financial condition, results of operations, credit rating or liquidity. Except to the extent required by applicable law or regulation, each of S&P Global and IHS Markit disclaims any duty to update any forward-looking statements contained in this communication or to otherwise update any of the above-referenced factors.

No Offer or Solicitation
This document is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Important Information About the Transaction and Where to Find It
In connection with the proposed transaction, S&P Global and IHS Markit will file relevant materials with the SEC, including a registration statement on Form S-4 filed by S&P Global to register the shares of S&P Global common stock to be issued in connection with the proposed transaction. The registration statement will include a joint proxy statement/prospectus which will be sent to the shareholders of S&P Global and IHS Markit seeking their approval of their respective transaction-related proposals.  INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT ON FORM S-4 AND THE RELATED JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT S&P GLOBAL, IHS MARKIT AND THE PROPOSED TRANSACTION. 

Investors and security holders may obtain copies of these documents free of charge through the website maintained by the SEC at www.sec.gov or from S&P Global at its website, or from IHS Markit at its website.  Documents filed with the SEC by S&P Global will be available free of charge by accessing S&P Global's website at www.spglobal.com under the heading Investor Relations, or, alternatively, by directing a request by telephone to 866-436-8502 (domestic callers) or 212-438-2192 (international callers) or by mail to S&P Global at Investor Relations, S&P Global Inc., 55 Water Street, New York, NY 10041, and documents filed with the SEC by IHS Markit will be available free of charge by accessing IHS Markit's website at www.ihsmarkit.com under the heading Investor Relations or, alternatively, by directing a request by telephone to 303-790-0600 or by mail to IHS Markit at IHS Markit Investor Relations and Corporate Communications, 15 Inverness Way East, Englewood, CO 80112.

Participants in the Solicitation
S&P Global, IHS Markit and certain of their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the shareholders of S&P Global and IHS Markit in respect of the proposed transaction under the rules of the SEC.  Information about IHS Markit's directors and executive officers is available in IHS Markit's Form 10-K for the year ended November 30, 2019, proxy statement dated February 28, 2020 for its 2020 Annual General Meeting of Shareholders, and certain of its Current Reports on Form 8-K. Information about S&P Global's directors and executive officers is available in S&P Global's Form 10-K for the year ended December 31, 2019, proxy statement dated March 30, 2020 for its 2020 Annual Meeting of Shareholders, and certain of its Current Reports on Form 8-K. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the transaction when they become available. Investors should read the joint proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from S&P Global or IHS Markit using the sources indicated above.

Contacts:

Investor Relations:

S&P Global
Chip Merritt
Senior Vice President, Investor Relations
(212) 438 4321
[email protected]
http://investor.spglobal.com

IHS Markit
Eric Boyer
Senior Vice President, Investor Relations
IHS Markit
(303) 397 2969
[email protected]
http://investor.ihsmarkit.com/ 

News Media:

S&P Global
Dave Guarino
Chief Communications Officer
(201) 755 5334
[email protected]

Ed Trissel / Tim Ragones
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

IHS Markit
Sebastian Kadritzke
[email protected]
+44-7939-227-676

SOURCE S&P Global

Related Links

https://www.spglobal.com/en/

Let's block ads! (Why?)

Article From & Read More ( S&P Global and IHS Markit to Merge in All-Stock Transaction Valuing IHS Markit at $44 Billion, Powering the Markets of the Future - PRNewswire )
https://ift.tt/37oKXIO
Business

Search

Featured Post

Stocks making the biggest moves premarket: American Airlines, AutoZone, GlaxoSmithKline and others - CNBC

In this article VIR TSLA GSK-GB DBI AZO AAL Check out the companies making headlines before the bell: American A...

Postingan Populer